Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 3 (TRIM3) is a cytoplasmic E3 ubiquitin ligase belonging to the TRIM-NHL protein family and characterized by a RING finger, two B-box domains, and a coiled-coil region[3][5]. TRIM3 acts as a tumor suppressor and is the human ortholog of the Drosophila 'brain tumor' (brat) protein[4]. It is involved in ubiquitination and degradation or stabilization of various substrate proteins, impacting cell cycle progression, growth suppression, and apoptosis regulation[2][3][4]. TRIM3 targets and ubiquitinates proteins such as P53, Estrogen receptor alpha, SLC7A11, and LDHA, thereby regulating tumorigenesis and metabolic adaptation in cancer cells[3][4]. Loss of TRIM3 expression is associated with increased cell proliferation, cancer stem cell phenotypes, resistance to apoptosis, and poor prognosis in several human cancers[4]. Additionally, TRIM3 may play a role in intracellular cargo transport via interaction with myosin V and alpha-actinin-4, and its domain structure allows complex regulation and protein-protein interactions typical of the diversified TRIM protein family[3][5][1].
Targeted protein ubiquitination (E3 ligase activity), Ubiquitination and degradation of specific substrates (e.g., P53, Estrogen receptor alpha, SLC7A11, lactate dehydrogenase A), Stabilization of target proteins via non-proteolytic ubiquitination
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 3 (TRIM3).